Trials of new laser surgery for farsightedness:
This article was originally published in Clinica
Autonomous Technologies has begun a trial of laser in situ keratomileusis (LASIK) in patients with hyperopia to see if the technique is less painful and offers shorter recovery time than conventional laser surgery. LASIK, in which the surgeon cuts a flap in the cornea, reshapes the tissue underneath using a laser and then replaces the flap, is already widely used in the US for nearsighted patients. The Orlando, Florida-based company has developed a device for tracking the eye and precisely controlling the laser beam.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
HBW Market News: FTC Ends Another Supplement Scam, Australia Win For ChromaDex, GOED Report, Herbalife
Herbalife opens 9,200 square-foot training facility in China; GOED's latest annual market report, covering 2017-2018, is available; ChromaDex has two-tear exclusivity for nicotinamide riboside chloride in Australia; and A.S. Research arthritis claims for Synovia end in FTC settlement.
Pharma sells the rights to Germany’s Cheplapharm, which obtained EU/Russia rights in October. Cerecor will acquire Aevi Genomics for $16.1m plus contingent value rights.